The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

Dubai: The Abu Dhabi investment firm Mubadala is putting in more funds into US-based PCI Pharma services, a leading player in ...

A successful monoclonal antibody could undergo scale-up several times across the span of its commercial life, each stage presenting new complexities during sterile fill-finish. As more sponsors turn ...

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Mubadala’s investment is part of a strategic transaction co-led by Bain Capital and existing lead investor Kohlberg ...

Bain and Kohlberg are leading an investment round in PCI Pharma Services, valuing it at $10 billion, as AI accelerates drug ...

Weekly companies-for-sale update, featuring two newly announced deals in fire safety and drug development; KKR announces ...

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

(Alliance News) - Partners Group Private Equity Ltd on Tuesday said its investment manager, Partners Group Holding AG, has agreed to exit its existing stake in PCI Pharma Services and reinvest as a ...

Mubadala Investment Company (Mubadala), announced the official commencement of the Al Maryah Waterfront enhancement project, ...